... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Acute myeloid leukemia Relapse Neutropenia Cytarabine D-index High-dose...

...Yang Liu; Lei Wen; Huan Chen; Yao Chen; Wenbing Duan; Ying Kang; Ling Ma; Xiaojun Huang; Jin Lu Background: Serum lactate dehydrogenase (LDH) is an adverse prognostic factor for newly diagnosed multiple myeloma (MM). However, the role of LDH in the prognosis of MM patients with relapse has not yet...

..., SWOG cytogenetic risk group, bone marrow (BM) and peripheral blood (PB) blast percentage, regimen intensity, and type of AML. At a median of 26 months after transplantation, OS, progression-free survival (PFS), non-relapse mortality, and relapse rates were 26, 24, 23, and 48%, respectively...

...Sanford Kempin; Zhuoxin Sun; Neil E. Kay; Elisabeth M. Paietta; Joseph J. Mazza; Rhett P. Ketterling; Olga Frankfurt; David F. Claxton; Joel N. Saltzman; Gordan Srkalovic; Natalie S. Callander; Gerald Gross; Martin S. Tallman Patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL...

... scant data in the literature on the frequency of patients who present with a normal karyotype and relapse with a sole trisomy 13. In our database of over 13,000 patients with myeloid neoplasms, we identified only 2 patients who had a normal karyotype at diagnosis and relapsed with sole trisomy 13 (∼0.01...

.... Brain Central nervous system Chronic lymphocytic leukemia Non-Hodgkin’s lymphoma Relapse Richter transformation A 56-year-old male was diagnosed with CLL, Binet A (immune phenotype: CD19+, CD5+, CD22dim, FMC7–, CD23+, kappa light chain restriction, CD 38.2%, and ZAP 70.7%), in July 2009...

... cells occurred, a further cycle with a scarcely myelotoxic drug, L-asparaginase, was administered: a 10/13 (76.9%) remission of the disease was then achieved. This therapeutic trial was well accepted and could be more extensively used in the patients in relapse. A remission lasting between 4 and 28...

...P.H.G. Hogeman; A.J.P. Veerman; D.R. Huismans; C. Van Zantwijk; P.D. Bezemer; I.H. Stamhuis; F.C. De Waal In 53 children with acute lymphoblastic leukaemia (ALL), initial handmirror cell (HMC) count among lymphoblasts was studied in relation to the occurrence of a relapse in the central nervous...

..., instructions or products referred to in the content or advertisements. Cyclophosphamide Cytotoxic drugs Long arm deletion of chromosome 7 Relapse 8;21 translocation Unrelated clone Acta Haematol 1990;83:159-162 © 1990 S. Karger AG. Basel 0001-5792/90/0833-0159 S 2.75/0 Long Arm Deletion...

...Romaine Viollier; André Tichelli In a previous study, we evaluated efficacy of repeated antilymphocyte globulin (ALG) treatment for patients with severe aplastic anemia not responding to an initial ALG treatment or relapsing after initial response to ALG. We now searched in the same cohort...